Lattice Biologics (Lattice Biologics) Dividend Payout Ratio : 0.00 (As of Jun. 2021)

View and export this data going back to 2001. Start your Free Trial

What is Lattice Biologics Dividend Payout Ratio?

Lattice Biologics's dividend payout ratio for the months ended in Jun. 2021 was 0.00.

The historical rank and industry rank for Lattice Biologics's Dividend Payout Ratio or its related term are showing as below:

LBLTF's Dividend Payout Ratio is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.4
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-04-29), the Dividend Yield % of Lattice Biologics is 0.00%.

Lattice Biologics's Dividends per Share for the months ended in Jun. 2021 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Lattice Biologics Dividend Payout Ratio Historical Data

The historical data trend for Lattice Biologics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Dividend Payout Ratio Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

Dividend Payout Ratio

Get a 7-Day Free Trial

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Lattice Biologics's Dividend Payout Ratio

For the Medical Devices subindustry, Lattice Biologics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Dividend Payout Ratio falls into.

Lattice Biologics Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Lattice Biologics's Dividend Payout Ratio for the fiscal year that ended in Sep. 2020 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Sep. 2020 )	/	EPS without NRI (A: Sep. 2020 )
	=	0	/	-0.009
	=	N/A

Lattice Biologics's Dividend Payout Ratio for the quarter that ended in Jun. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2021 )	/	EPS without NRI (Q: Jun. 2021 )
	=	0	/	-0
	=	N/A

Lattice Biologics (OTCPK:LBLTF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Lattice Biologics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (Lattice Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (OTCPK:LBLTF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (Lattice Biologics) Headlines

No Headlines